The scientific standing of psychoanalysis

Author/s Mark Solms
Publishing Year 2018 Issue 2018/1 Language Italian
Pages 10 P. 7-16 File size 80 KB
DOI 10.3280/PU2018-001001
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

The core scientific claims of psychoanalysis are summarized, and synthetic answers are given to the following three questions: (a) How does the emotional mind work, in health and disease? (b) What does psychoanalytic treatment aim to achieve? (c) How effective is it? While there are disagreements regarding specific details, there is a general agreement on some core claims of psychoanalysis. These core claims enjoy strong empirical support and are "evidence-based". Psychoanalytic treatment is highly effective, often superior to cognitive-behavior therapy and to medication.

Keywords: Psychoanalysis and scientific research; Neurobiology; Mental functioning; Theory of psychoanalytic therapy; Efficacy of psychodynamic therapy

  1. Abbass A.A., Hancock J.T., Henderson J. & Kisely S. (2006). Short-term psychodynamic psy-chotherapies for common mental disorders. Cochrane Database of Systematic Reviews, 4: CD004687.
  2. Abbass A.A., Kisely S.R., Town J.M., Leichsenring F., Driessen E., De Maat S., Gerber A., Dekker J., Rabung S., Rusalovska S. & Crowe E. (2014). Short-term psychodynamic psychotherapies for common mental disorders (Update). Cochrane Database of Systematic Re-views, 7: CD004687.
  3. American Psychological Association (2013). Recognition of psychotherapy effectiveness. Psychotherapy, 50, 1: 102-109.
  4. Bargh J.A. & Chartrand T.L. (1999). The unbearable automaticity of being. American Psychologist, 54, 7: 462-479. DOI: 10.1037/0003-066X.54.7.462
  5. Beauregard M. (2014). Functional neuroimaging studies of the effects of psychotherapy. Dialogues of Clinical Neuroscience, 16, 1: 75-81.
  6. Blagys M.D. & Hilsenroth M.J. (2000). Distinctive activities of short-term psychodynamic-interpersonal psychotherapy: A review of the comparative psychotherapy process literature. Clinical Psychology: Science and Practice, 7, 2: 167-188.
  7. De Maat S., de Jonghe F., Schoevers R. & Dekker J. (2009). The effectiveness of long-term psychoanalytic therapy: A systematic review of empirical studies. Harvard Review of Psychiatry, 17, 1: 1-23. DOI: 10.1080/10673220902742476
  8. Eagle M.N. (1987). The psychoanalytic and the cognitive unconscious. In: Stern R., editor, Theories of the Unconscious and Theories of the Self. Hillsdale, NJ: Analytic Press, 1987, pp. 155-189 (trad. it.: L’inconscio psicoanalitico e l’inconscio cognitivo. In: Conte M. & Gennaro A., a cura di, Inconscio e processi cognitivi. Bologna: Il Mulino, 1989, pp. 33-73).
  9. Freud S. (1914). Introduzione al narcisismo. Opere, 7: 441-472. Torino: Boringhieri, 1975.
  10. Freud S. (1915). Pulsioni e loro destini. Opere, 8: 13-35. Torino: Boringhieri, 1976.
  11. Hayes A.H., Castonguay L.G. & Goldfried M.R. (1996). The effectiveness of targeting the vulnerability factors of depression in cognitive therapy. Journal of Consulting and Clinical Psychology, 64, 3: 623-627. DOI: 10.1037/0022-006X.64.3.623
  12. Kandel E.R. (1999). Biology and the future of psychoanalysis: A new intellectual framework for psychiatry revisited. American Journal of Psychiatry, 156, 4: 505­524. Anche in: Psychiatry, Psychoanalysis, and the New Biology of Mind. Washington, DC: American Psychiatric Publishing, 2005, ch. 3, pp. 63-106 (trad. it.: La biologia e il futuro della psicoanalisi: una nuova cornice intellettuale per una psichiatria rivisitata. Setting, 2001, 11: 27-76. Anche in: Psichiatria, psicoanalisi e nuova biologia della mente. Milano: Raffaello Cortina, 2007, cap. 3, pp. 75-124).
  13. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J. & Johnson B.T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5, 2: e45.
  14. Kirsch I. (2009). The Emperor’s New Drugs: Exploding the Antidepressant Myth. London: The Bodley Head (trad. it.: I farmaci antidepressivi: il crollo di un mito. Dalle pillole della felicità alla cura integrata. Milano: Tecniche Nuove, 2012).
  15. Leichsenring F. & Steinert C. (2017). La terapia cognitivo-comportamentale è veramente la più efficace? Psicoterapia e Scienze Umane, 51, 4: 551-558. DOI: 10.3280/PU2017-004003
  16. Leuzinger-Bohleber M., Hautzinger M., Fiedler G., Keller W., Bahrke U., Kallenbach L., Kaufhold J., Ernst M., Negele A., Schött M., Küchenhoff H., Günther F., Rüger B. & Beutel M. (2018). Outcome of psychoanalytic and cognitive-behavioral therapy with chronic depressed patients. A controlled trial with preferential and randomized allocation. British Journal of Psychiatry (submitted).
  17. Nader K., Shafe G.E & Le Doux J.E. (2000). Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature, 406, 6797: 722-726.
  18. Norcross J.C. (2005). The psychotherapist’s own psychotherapy: Educating and developing psychologists. American Psychologist, 60: 840-850. DOI: 10.1037/0003-066X.60.8.840
  19. Panksepp J. (1998). Affective Neuroscience. Oxford University Press.
  20. Panksepp J. & Biven L. (2012). The Archaeology of Mind: Neuroevolutionary Origins of Hu-man Emotions. New York: Norton (trad. it.: Archeologia della mente: origini neuroevolutive delle emozioni umane. Milano: Raffaello Cortina, 2014).
  21. Sara S.J. (2000). Retrieval and reconsolidation: Toward a neurobiology of remembering. Learning & Memory, 7, 2: 73-84.
  22. Shedler J. (2010). The efficacy of psychodynamic therapy. American Psychologist, 65, 2: 98-109.
  23. Solms M. (2017). What is “the unconscious” and where is it located in the brain? A neuropsychoanalytic perspective. Annals of the New York Academy of Sciences, 1406, 1: 90-97.
  24. Steinert C., Munder T., Rabung S., Hoyer J. & Leichsenring F. (2017). Psychodynamic therapy: As efficacious as other empirically supported treatments? A meta-analysis testing equivalence of outcomes. American Journal of Psychiatry, 174, 10: 943-953.
  25. Tronson N.C. & Taylor J.R. (2007). Molecular mechanisms of memory reconsolidation. Nature Reviews Neuroscience, 8, 4: 262-275.
  26. Turner E.H., Matthews A.M., Linardatos E., Tell R.A. & Rosenthal R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358, 3: 252-260.
  27. Westen D. (1999). The scientific status of unconscious processes: Is Freud really dead? Journal of the American Psychoanalytic Association, 47, 4: 1061-1106 (trad. it.: Lo status scientifico dei processi inconsci: Freud è davvero morto? Psicoterapia e Scienze Umane, 2001, XXXV, 4: 5-58).
  28. Westen D., Morrison Novotny K. & Thompson-Brenner H. (2004). The empirical status of empirically supported psychotherapies: Assumptions, findings, and reporting in controlled clinical trials. Psychological Bulletin, 130: 631-663 (trad. it.: Lo statuto empirico delle psicoterapie validate empiricamente: assunti, risultati e pubblicazione delle ricerche. Psicoterapia e Scienze Umane, 2005, XXXIX, 1: 7-90). Anche in: PDM Task Force, Psychodynamic Diagnostic Manual (PDM). Silver Spring, MD: Alliance of Psychoanalytic Organizations, 2006, pp. 565-658 (trad. it.: PDM. Manuale Diagnostico Psicodinamico. Milano: Raffaello Cortina, 2008, pp. 691-764). Una sintesi su Internet a cura di Paolo Migone:

Mark Solms, Psicoanalisi e ricerca scientifica in "PSICOTERAPIA E SCIENZE UMANE" 1/2018, pp 7-16, DOI: 10.3280/PU2018-001001